{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:52:29Z","timestamp":1793609549970,"version":"4.5.0"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS096994"],"award-info":[{"award-number":["NS096994"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS111316"],"award-info":[{"award-number":["NS111316"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P50HD103557"],"award-info":[{"award-number":["P50HD103557"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.nbd.2021.105574","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T11:18:25Z","timestamp":1638011905000},"page":"105574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway"],"prefix":"10.1016","volume":"162","author":[{"given":"Joshua","family":"Barry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh T.N.","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Cepeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105574_bb0005","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/jnr.23889","article-title":"Altered membrane properties and firing patterns of external globus pallidus neurons in the R6\/2 mouse model of Huntington\u2019s disease","volume":"94","author":"Akopian","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.ne.09.030186.002041","article-title":"Parallel organization of functionally segregated circuits linking basal ganglia and cortex","volume":"9","author":"Alexander","year":"1986","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1523\/JNEUROSCI.3539-10.2011","article-title":"Differential electrophysiological changes in striatal output neurons in Huntington\u2019s disease","volume":"31","author":"Andre","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49995","article-title":"An open cortico-basal ganglia loop allows limbic control over motor output via the nigrothalamic pathway","volume":"8","author":"Aoki","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2021.105574_bb0030","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1212\/WNL.0b013e318263c443","article-title":"Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Armstrong","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2021.105574_bb0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21616","article-title":"Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington\u2019s disease","volume":"5","author":"Atherton","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2021.105574_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2006.10.028","article-title":"Change in MRI striatal volumes as a biomarker in preclinical Huntington\u2019s disease","volume":"72","author":"Aylward","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2021.105574_bb0045","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/0006-2952(83)90388-X","article-title":"Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine","volume":"32","author":"Bagchi","year":"1983","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2021.105574_bb0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuron.2016.11.035","article-title":"Huntingtin-mediated multipolar-bipolar transition of newborn cortical neurons is critical for their postnatal neuronal morphology","volume":"93","author":"Barnat","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0055","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1523\/JNEUROSCI.0434-18.2018","article-title":"Striatal direct and indirect pathway output structures are differentially altered in mouse models of Huntington\u2019s disease","volume":"38","author":"Barry","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0060","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/jnr.24710","article-title":"Mechanisms underlying the enhancement of gamma-aminobutyric acid responses in the external globus pallidus of R6\/2 Huntington\u2019s disease model mice","volume":"98","author":"Barry","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0065","article-title":"The PDE1\/5 inhibitor SCH-51866 does not modify disease progression in the R6\/2 mouse model of Huntington\u2019s disease","volume":"6","author":"Beaumont","year":"2014","journal-title":"PLoS Curr."},{"key":"10.1016\/j.nbd.2021.105574_bb0070","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuron.2016.10.064","article-title":"Phosphodiesterase 10A inhibition improves Cortico-basal ganglia function in Huntington\u2019s disease models","volume":"92","author":"Beaumont","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cne.902990206","article-title":"Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum","volume":"299","author":"Berendse","year":"1990","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0080","series-title":"Stem Cell-Derived Human Striatal Progenitors Innervate Striatal Targets and Alleviate Sensorimotor Deficit in a Rat Model of Huntington Disease","author":"Besusso","year":"2020"},{"key":"10.1016\/j.nbd.2021.105574_bb0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fncel.2020.00146","article-title":"Neuronal replacement as a tool for basal ganglia circuitry repair: 40 years in perspective","volume":"14","author":"Bjorklund","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0090","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1007\/s10072-021-05527-1","article-title":"Deep brain stimulation in Huntington\u2019s disease: a literature review","volume":"42","author":"Bonomo","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.nbd.2021.105574_bb0095","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/7854_2013_256","article-title":"Mouse models of Huntington\u2019s disease","volume":"22","author":"Brooks","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"642\u201357","key":"10.1016\/j.nbd.2021.105574_bb0100","article-title":"Striatal projection neurons require huntingtin for synaptic connectivity and survival","volume":"30","author":"Burrus","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2021.105574_bb0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nbd.2015.03.006","article-title":"Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington\u2019s disease","volume":"78","author":"Callahan","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0110","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1113\/JP270268","article-title":"Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6\/2 mouse model of Huntington\u2019s disease","volume":"593","author":"Callahan","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2021.105574_bb0115","series-title":"Dysregulation of the Basal Ganglia Indirect Pathway Prior to Cell Loss in the Q175 Mouse Model of Huntington\u2019s Disease BioRxiv","author":"Callahan","year":"2021"},{"key":"10.1016\/j.nbd.2021.105574_bb0120","article-title":"Synaptic dysfunction in Huntington\u2019s disease: lessons from genetic animal models","author":"Cepeda","year":"2020","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2021.105574_bb0125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1523\/JNEUROSCI.23-03-00961.2003","article-title":"Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington\u2019s disease","volume":"23","author":"Cepeda","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0130","series-title":"Rescuing the Corticostriatal Synaptic Disconnection in the R6\/2 Mouse Model of Huntington\u2019s Disease: Exercise, Adenosine Receptors and Ampakines","author":"Cepeda","year":"2010"},{"key":"10.1016\/j.nbd.2021.105574_bb0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-63425-2.00010-6","article-title":"The role of dopamine in huntington\u2019s disease","volume":"211","author":"Cepeda","year":"2014","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0140","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/jnr.24503","article-title":"Developmental origins of cortical hyperexcitability in Huntington\u2019s disease: review and new observations","volume":"97","author":"Cepeda","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0145","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3389\/fnins.2020.00466","article-title":"Phosphodiesterase 9A inhibition facilitates Corticostriatal transmission in wild-type and transgenic rats that model Huntington\u2019s disease","volume":"14","author":"Chakroborty","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mds.27054","article-title":"Seventy years with the Globus pallidus: pallidal surgery for movement disorders between 1947 and 2017","volume":"32","author":"Cif","year":"2017","journal-title":"Mov. Disord."},{"issue":"Pt 2","key":"10.1016\/j.nbd.2021.105574_bb0155","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1469-7793.2000.t01-1-00291.x","article-title":"Electrophysiological and morphological characteristics of three subtypes of rat globus pallidus neurone in vitro","volume":"527","author":"Cooper","year":"2000","journal-title":"J. Physiol."},{"key":"10.1016\/j.nbd.2021.105574_bb0160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40478-020-0878-0","article-title":"Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington\u2019s disease","volume":"8","author":"Crevier-Sorbo","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2021.105574_bb0165","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1523\/JNEUROSCI.2306-20.2021","article-title":"Striatal direct pathway targets Npas1(+) Pallidal neurons","volume":"41","author":"Cui","year":"2021","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0170","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1523\/JNEUROSCI.1592-09.2009","article-title":"Alterations in cortical excitation and inhibition in genetic mouse models of Huntington\u2019s disease","volume":"29","author":"Cummings","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000375126","article-title":"Dysfunctional dopaminergic Neurones in mouse models of Huntington\u2019s disease: a role for SK3 channels","volume":"15","author":"Dallerac","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0180","first-page":"A99.3","article-title":"A randomized, double-blind, placebo-controlled phase ii efficacy and safety study of the PDE10A inhibitor PF-02545920 in Huntington disease (amaryllis)","volume":"89","author":"Delnomdedieu","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105574_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.64.1.20","article-title":"Circuits and circuit disorders of the basal ganglia","volume":"64","author":"DeLong","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0190","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1002\/cne.24013","article-title":"Cholinergic interneurons in the Q140 knock-in mouse model of Huntington\u2019s disease: reductions in dendritic branching and thalamostriatal input","volume":"524","author":"Deng","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2021.105574_bb0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2013.08.009","article-title":"Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington\u2019s disease mice","volume":"60","author":"Deng","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0205","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnsys.2014.00198","article-title":"Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington\u2019s disease","volume":"8","author":"Deng","year":"2014","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0210","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/cne.25023","article-title":"Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington\u2019s disease mice","volume":"529","author":"Deng","year":"2021","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0215","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuron.2010.06.017","article-title":"Thalamic gating of corticostriatal signaling by cholinergic interneurons","volume":"67","author":"Ding","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0220","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nn.3003","article-title":"Semaphorin 3E-Plexin-D1 signaling controls pathway-specific synapse formation in the striatum","volume":"15","author":"Ding","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0225","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1523\/JNEUROSCI.1623-10.2010","article-title":"Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatum","volume":"30","author":"Doig","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0230","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington\u2019s disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105574_bb0235","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.nbd.2021.105574_bb0240","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/WCO.0000000000000835","article-title":"Therapeutic strategies for Huntington\u2019s disease","volume":"33","author":"Estevez-Fraga","year":"2020","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57017","article-title":"M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington\u2019s disease","volume":"9","author":"Fernandez-Garcia","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.nbd.2021.105574_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005072-198701000-00002","article-title":"Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington\u2019s disease","volume":"46","author":"Ferrante","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0255","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1523\/JNEUROSCI.11-12-03877.1991","article-title":"Proliferative and degenerative changes in striatal spiny neurons in Huntington\u2019s disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry","volume":"11","author":"Ferrante","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0260","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41586-021-03993-3","article-title":"The mouse cortico-basal ganglia-thalamic network","volume":"598","author":"Foster","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2021.105574_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","article-title":"The neostriatal mosaic: multiple levels of compartmental organization","volume":"15","author":"Gerfen","year":"1992","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013417","article-title":"Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington\u2019s disease","volume":"5","author":"Giampa","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105574_bb0275","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","article-title":"Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis","volume":"67","author":"Godin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0280","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.3155875","article-title":"Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington\u2019s disease","volume":"227","author":"Graveland","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.nbd.2021.105574_bb0285","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0290","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchemneu.2003.10.003","article-title":"The primate basal ganglia: parallel and integrative networks","volume":"26","author":"Haber","year":"2003","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2021.105574_bb0295","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0300","first-page":"309","article-title":"Parvalbumin immunoreactive neurons resist degeneration in Huntington\u2019s disease striatum","volume":"50","author":"Harrington","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0305","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington\u2019s disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0310","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2021.105574_bb0315","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/ejn.13196","article-title":"The external Globus pallidus: Progress and perspectives","volume":"43","author":"Hegeman","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050717","article-title":"Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington\u2019s disease","volume":"7","author":"Heikkinen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105574_bb0325","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/nn.4332","article-title":"The mouse cortico-striatal projectome","volume":"19","author":"Hintiryan","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0330","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0335","series-title":"Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6\/2 Mouse Model of Huntington\u2019s Disease","author":"Holley","year":"2015"},{"key":"10.1016\/j.nbd.2021.105574_bb0340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/cns.12839","article-title":"Therapeutic effects of stem cells in rodent models of Huntington\u2019s disease: review and electrophysiological findings","volume":"24","author":"Holley","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.nbd.2021.105574_bb0345","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fnsyn.2019.00014","article-title":"Major contribution of somatostatin-expressing interneurons and cannabinoid receptors to increased GABA synaptic activity in the striatum of Huntington\u2019s disease mice","volume":"11","author":"Holley","year":"2019","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0350","first-page":"RRN1192","article-title":"QEEG measures in Huntington\u2019s disease: a pilot study","volume":"2","author":"Hunter","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.nbd.2021.105574_bb0355","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2021.105574_bb0360","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1471-4159.2006.03762.x","article-title":"Dopamine release is severely compromised in the R6\/2 mouse model of Huntington\u2019s disease","volume":"97","author":"Johnson","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2021.105574_bb0365","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.5687-08.2009","article-title":"Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease","volume":"29","author":"Joshi","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0370","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.24162","article-title":"Cortical interneuron loss and symptom heterogeneity in Huntington disease","volume":"75","author":"Kim","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0375","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0006-8993(91)91466-E","article-title":"Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation","volume":"564","author":"Kita","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0380","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington\u2019s disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2021.105574_bb0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.nbd.2015.11.020","article-title":"Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model","volume":"86","author":"Kolodziejczyk","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0390","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin\u2019s effects on striatal gene expression in mice recapitulate changes observed in human Huntington\u2019s disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/d41586-021-01177-7","article-title":"Failure of genetic therapies for Huntington's devastates community","volume":"593","author":"Kwon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2021.105574_bb0400","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0306-4522(92)90293-B","article-title":"Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat","volume":"51","author":"Lapper","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2021.105574_bb0405","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aba4624","article-title":"Antisense oligonucleotides for neurodegeneration","volume":"367","author":"Leavitt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.nbd.2021.105574_bb0410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fneur.2017.00091","article-title":"Quantitative electroencephalographic biomarkers in preclinical and human studies of Huntington\u2019s disease: are they fit-for-purpose for treatment development?","volume":"8","author":"Leuchter","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0415","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tins.2004.08.008","article-title":"Genetic mouse models of Huntington\u2019s and Parkinson\u2019s diseases: illuminating but imperfect","volume":"27","author":"Levine","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0420","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molmed.2003.08.006","article-title":"Huntington\u2019s disease: a synaptopathy?","volume":"9","author":"Li","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2021.105574_bb0425","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cns.12817","article-title":"Cause or compensation?-altered neuronal ca(2+) handling in Huntington\u2019s disease","volume":"24","author":"Mackay","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"636\u201352","key":"10.1016\/j.nbd.2021.105574_bb0430","article-title":"Distinct cortical-thalamic-striatal circuits through the Parafascicular nucleus","volume":"102","author":"Mandelbaum","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0435","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105574_bb0440","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4103\/1673-5374.308077","article-title":"Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders","volume":"16","author":"Marshall","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0445","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington\u2019s disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0450","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1152\/jn.90606.2008","article-title":"Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington\u2019s disease","volume":"100","author":"Miller","year":"2008","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2021.105574_bb0455","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1073\/pnas.1603871113","article-title":"Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington\u2019s disease","volume":"113","author":"Molero","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105574_bb0460","doi-asserted-by":"crossref","first-page":"10034","DOI":"10.1523\/JNEUROSCI.0715-14.2014","article-title":"Mutant huntingtin affects cortical progenitor cell division and development of the mouse neocortex","volume":"34","author":"Molina-Calavita","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0465","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0361-9230(01)00611-6","article-title":"Abnormalities in the synaptic vesicle fusion machinery in Huntington\u2019s disease","volume":"56","author":"Morton","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2021.105574_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2011.12.040","article-title":"Abnormal burst patterns of single neurons recorded in the substantia nigra reticulata of behaving 140 CAG Huntington\u2019s disease mice","volume":"512","author":"Murphy-Nakhnikian","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2021.105574_bb0475","article-title":"Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington\u2019s disease","author":"Nair","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105574_bb0480","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105574_bb0485","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","article-title":"Smaller intracranial volume in prodromal Huntington\u2019s disease: evidence for abnormal neurodevelopment","volume":"134","author":"Nopoulos","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2021.105574_bb0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2011.01.036","article-title":"Impaired dopamine release and uptake in R6\/1 Huntington\u2019s disease model mice","volume":"492","author":"Ortiz","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2021.105574_bb0495","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2012.02.042","article-title":"Motor function and dopamine release measurements in transgenic Huntington\u2019s disease model rats","volume":"1450","author":"Ortiz","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0500","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/JHD-160217","article-title":"Embryonic mutant huntingtin aggregate formation in mouse models of Huntington\u2019s disease","volume":"5","author":"Osmand","year":"2016","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0505","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00702-010-0491-7","article-title":"Comparative EEG mapping studies in Huntington\u2019s disease patients and controls","volume":"117","author":"Painold","year":"2010","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2021.105574_bb0510","first-page":"545","article-title":"Tetrabenazine in the treatment of Huntington\u2019s disease","volume":"3","author":"Paleacu","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.nbd.2021.105574_bb0515","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cne.903440211","article-title":"Multiple striatal representation in primate substantia nigra","volume":"344","author":"Parent","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2017.07.020","article-title":"Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6\/2 mouse model of Huntington\u2019s disease","volume":"108","author":"Parievsky","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0525","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5607\/en.2018.27.3.217","article-title":"Cortical axonal secretion of BDNF in the striatum is disrupted in the mutant-huntingtin Knock-in mouse model of Huntington\u2019s disease","volume":"27","author":"Park","year":"2018","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105574_bb0530","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13082","article-title":"Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington\u2019s disease mouse model","volume":"54","author":"Park","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.nbd.2021.105574_bb0535","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/jnnp.2007.128728","article-title":"Detection of Huntington\u2019s disease decades before diagnosis: the Predict-HD study","volume":"79","author":"Paulsen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105574_bb0540","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/mds.27622","article-title":"Enhanced striatopallidal gamma-aminobutyric acid (GABA)a receptor transmission in mouse models of huntington\u2019s disease","volume":"34","author":"Perez-Rosello","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105574_bb0545","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1155\/2013\/705373","article-title":"The pathophysiology and pharmacological treatment of Huntington disease","volume":"26","author":"Pidgeon","year":"2013","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0550","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0555","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1073858418807887","article-title":"Thinking outside the box (and arrow): current themes in striatal dysfunction in movement disorders","volume":"25","author":"Plotkin","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2021.105574_bb0560","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.conb.2015.01.020","article-title":"Corticostriatal synaptic adaptations in Huntington\u2019s disease","volume":"33","author":"Plotkin","year":"2015","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105574_bb0565","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/hmg\/dds037","article-title":"Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice","volume":"21","author":"Pouladi","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0570","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington\u2019s disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2021.105574_bb0575","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","article-title":"Regional white matter change in pre-symptomatic Huntington\u2019s disease: a diffusion tensor imaging study","volume":"140","author":"Reading","year":"2005","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.nbd.2021.105574_bb0580","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neuroscience.2005.08.062","article-title":"Hyperactive striatal neurons in symptomatic Huntington R6\/2 mice: variations with behavioral state and repeated ascorbate treatment","volume":"137","author":"Rebec","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2021.105574_bb0585","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.stemcr.2017.11.005","article-title":"Human neural stem cell transplantation rescues functional deficits in R6\/2 and Q140 Huntington\u2019s disease mice","volume":"10","author":"Reidling","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.nbd.2021.105574_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2003.11.002","article-title":"Can lesions of GPe correct HD deficits?","volume":"186","author":"Reiner","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0595","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105574_bb0600","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/mds.25624","article-title":"Striatal parvalbuminergic neurons are lost in Huntington\u2019s disease: implications for dystonia","volume":"28","author":"Reiner","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105574_bb0605","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2021.105574_bb0610","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","article-title":"Diffusion tensor imaging in presymptomatic and early Huntington\u2019s disease: selective white matter pathology and its relationship to clinical measures","volume":"21","author":"Rosas","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105574_bb0615","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The biology of huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0620","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington\u2019s disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105447","article-title":"Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington\u2019s disease","volume":"157","author":"Shobe","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0630","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0635","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.tins.2004.07.004","article-title":"The thalamostriatal system: a highly specific network of the basal ganglia circuitry","volume":"27","author":"Smith","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0640","doi-asserted-by":"crossref","first-page":"16102","DOI":"10.1523\/JNEUROSCI.4634-11.2011","article-title":"Thalamic contributions to basal ganglia-related behavioral switching and reinforcement","volume":"31","author":"Smith","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0645","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0650","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fnsys.2016.00102","article-title":"Cholinergic interneurons amplify Corticostriatal synaptic responses in the Q175 model of Huntington\u2019s disease","volume":"10","author":"Tanimura","year":"2016","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0655","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2021.105574_bb0660","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington\u2019s disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2021.105574_bb0665","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0670","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/7854_2014_354","article-title":"The neuropathology of Huntington\u2019s disease","volume":"22","author":"Waldvogel","year":"2015","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0675","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1523\/JNEUROSCI.2804-08.2008","article-title":"Altered information processing in the prefrontal cortex of Huntington\u2019s disease mouse models","volume":"28","author":"Walker","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105574_bb0680","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuron.2013.05.014","article-title":"Differential innervation of direct- and indirect-pathway striatal projection neurons","volume":"79","author":"Wall","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0685","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuron.2017.03.017","article-title":"Genetically distinct parallel pathways in the Entopeduncular nucleus for limbic and sensorimotor output of the basal ganglia","volume":"94","author":"Wallace","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2021.105574_bb0690","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","article-title":"Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus","volume":"17","author":"Warby","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0695","first-page":"6","article-title":"Deep brain stimulation in Huntington\u2019s disease-preliminary evidence on pathophysiology, efficacy and safety","author":"Wojtecki","year":"2016","journal-title":"Brain Sci."},{"key":"10.1016\/j.nbd.2021.105574_bb0700","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41467-020-14855-3","article-title":"Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington\u2019s disease","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2021.105574_bb0705","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2021.105574_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105453","article-title":"Nanoscale synapse organization and dysfunction in neurodevelopmental disorders","volume":"158","author":"Zieger","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105574_bb0715","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrneurol.2009.54","article-title":"Brain-derived neurotrophic factor in neurodegenerative diseases","volume":"5","author":"Zuccato","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2021.105574_bb0720","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington\u2019s disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121003235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121003235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:29:15Z","timestamp":1760851755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121003235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":144,"alternative-id":["S0969996121003235"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105574","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synaptic pathology in Huntington's disease: Beyond the corticostriatal pathway","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105574"}}